Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Colorectal Cancer
 More »

  • Molecular Imaging Driving Development
    ... measure mutational status in lung cancer and using advanced imaging tools to distinguish K-ras from wild-type mutations in colorectal cancer, as well as ER+ from ER- breast cancer. ...
    8-1-2013
  • VolitionRx Taps Innova Biotinylation Tech in Licensing Deal
    In addition, the firm will also use Innova technology for the development of Nucleosomics®-based clinical tests, including a blood-based test for colorectal cancer. "The addition ...
    7-22-2013
  • Top 15 Job-Cutting Companies of 2013 (So Far)
    ... But Astellas remains a partner with Aveo in the upcoming BATON Phase II clinical trials of tivozanib in triple negative breast cancer and metastatic colorectal cancer. Aveo expects ...
    7-11-2013
  • Cancer's Bitter Medicine
    ... Memorial Sloan-Kettering Cancer Center, where physicians refused to prescribe Zaltrap (ziv-aflibercept) for metastatic colorectal cancer due to its initial $11,000-per-month cost. ...
    6-15-2013
  • Study: Genetic Testing Uptake within Cancer-Affected Families...
    in testing for breast and ovarian cancer-associated BRCA1 and BRCA2, the same could not be said for the MMR mutation, which is implicated in a form of colorectal cancer. Dr. ...
    6-10-2013
  • FDA Rejects Aveo's Tivozanib for RCC; Rips Phase III Results
    Aveo responded June 5 by announcing plans to eliminate 140 jobs or 62% of its workforce, and reposition the experimental kidney cancer drug for colorectal and breast cancer. At the ...
    6-10-2013
  • Biomarker Study Suggests Potential Alternative to Colonoscopy
    Early detection of colorectal cancer (CRC) can improve average patient survival significantly, but many show resistance to the invasive nature of traditional colonoscopies, and ...
    6-7-2013
  • Aveo's "Sad Day": 62% of Workforce Lose Jobs
    kidney cancer drug for colorectal and breast cancer. "I'm sorry the results weren't as we had hoped, sorry for the employees, sorry for the investors, and sorry for the patients. ...
    6-5-2013
  • 10 Biotechnologies Yet to Live Up to the Hype
    with kidney failure, HIV, or cancer; and Avastin for metastatic colorectal cancer, advanced nonsquamous non-small cell lung cancer, metastatic kidney cancer, and glioblastoma. ...
    6-5-2013
  • Acquired Drug Resistance in Cancer
    ... Genetics and Therapeutics, Johns Hopkins Kimmel Cancer Center reported blood-based molecular detection of acquired resistance to anti-EGFR therapies in colorectal cancer patients. ...
    6-1-2013
  • Amgen, Astellas Join Forces in Japan
    On May 10, Amgen announced plans to commercialize its metastatic colorectal cancer drug (mCRC) Vectibix® (panitumumab) in China through a joint alliance with Chinese-owned ...
    5-29-2013
  • Cancer's Bitter Medicine
    ... Memorial Sloan-Kettering Cancer Center, where physicians refused to prescribe Zaltrap (ziv-aflibercept) for metastatic colorectal cancer due to its initial $11,000-per-month cost. ...
    5-21-2013
  • Pharma Touting Phase II/III Wins in Run-Up to ASCO
    Presenting preliminary results of three analyses of Vectibix® (panitumumab) in combination with FOLFOX as a first-line treatment for metastatic colorectal cancer, Amgen today said ...
    5-16-2013
  • Softening the Blow from FOLFOX Treatment
    to reposition the MRI contrast agent mangafodipir, a PyridoxyL EthylDiamine (PLED)-derivative, into a drug candidate for colorectal cancer patients undergoing chemotherapy. ...
    5-15-2013
  • Lilly Halts Development of Lymphoma Drug After Phase III Failure
    ... Those two Phase III molecules are necitumumab, indicated for squamous non-small cell lung cancer; and ramucirumab for breast cancer, colorectal cancer, and gastric cancer. Lilly ...
    5-10-2013
  • More »

    Journal Articles

  • Impact of Pre-Storage and Bedside Filtered Leukocyte-Depleted...
    Mattia Garancini, Luca Degrate, Maria Rosaria Carpinelli, Matteo Maternini, Fabio Uggeri, Laura Giordano, Franco Uggeri, Fabrizio Romano
    Surgical Infections
    on Infective Morbidity after Colorectal Resection: A Single-Center Analysis of ... Prolonged operation (P=0.035), ASA score=3 (P=0.023), diagnosis of cancer vs benign ...
  • Metronidazole Decreases Viability of DLD-1 Colorectal Cancer...
    Anna Sadowska, Rafal Kretowski, Beata Szynaka, Marzanna Cechowska-Pasko, Halina Car
    Cancer Biotherapy and Radiopharmaceuticals
    Metronidazole Decreases Viability of DLD-1 Colorectal Cancer Cell Line Cancer Biotherapy and Radiopharmaceuticals The aim of our study was to evaluate the impact of metronidazole ...
  • The Efficacy of Additional Bevacizumab to Cytotoxic Chemotherapy...
    Chao Lv, Shuodong Wu, Duo Zheng, Yuli Wu, Dianbo Yao, Xiaopeng Yu
    Cancer Biotherapy and Radiopharmaceuticals
    The Efficacy of Additional Bevacizumab to Cytotoxic Chemotherapy Regimens for the Treatment of Colorectal Cancer: An Updated Meta-Analysis for Randomized Trials Cancer Biotherapy ...
  • Detection of Surface Antigen 17-1A in Breast and Colorectal Cancer
    J. PACKEISEN, CH. KAUP-FRANZEN, H.-J. KNIERIEM
    Hybridoma
    Detection of Surface Antigen 17-1A in Breast and Colorectal Cancer Hybridoma

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Top Paid Women in Biopharma

Do you think the women on our list of the 20 top paid women executives in biopharma are underpaid?

Suggest a Poll